南京医药集团股份有限公司2026年第一次临时股东会决议公告

Group 1 - The company held its first extraordinary general meeting of shareholders for 2026 on February 5, 2026, at a designated location in Nanjing [2][3] - All resolutions presented at the meeting were approved, including changes to the purpose of repurchased shares and amendments to the company's articles of association [4][5] - The meeting was conducted in compliance with relevant laws and regulations, with a legal opinion confirming the validity of the proceedings [5][6] Group 2 - The company decided to change the purpose of 39,852 repurchased shares from "for employee stock ownership plans or equity incentives" to "for cancellation and reduction of registered capital" [7][8] - Following the cancellation of the repurchased shares, the total share capital will decrease from 1,308,931,240 shares to 1,308,891,388 shares, and the registered capital will be reduced to 1,308,891,388 yuan [8] - Creditors have a 30-day period from the notification date to claim their debts or request guarantees, with specific documentation required for claims [9]